PMU-Autor/inn/en
Sellner JohannAbstract
Adverse outcome in bacterial meningitis is associated with the breakdown of the blood-brain barrier (BBB). Matrix-metalloproteinases (MMPs) facilitate this process by degradation of components of the BBB. This in turn results in acute complications of bacterial meningitis including edema formation, increased intracranial pressure and subsequent ischemia. We determined the parenchymal balance of MMP-9 and TIMP-1 (tissue inhibitor of MMP) and the structural integrity of the BBB in relation to cortical damage in an infant rat model of pneumococcal meningitis. The data demonstrate that the extent of cortical damage is significantly associated with parenchymal gelatinolytic activity and collagen type IV degradation. The increased gelatinolysis was found to be associated with a brain parenchymal imbalance of MMP-9/TIMP-1. These findings provide support to the concept that MMPs mediated disruption of the BBB contributes to the pathogenesis of bacterial meningitis and that protection of the vascular unit may have neuroprotective potential.
Useful keywords (using NLM MeSH Indexing)
Animals
Animals, Newborn
Blood-Brain Barrier/pathology
Blotting, Western
Cerebral Cortex/metabolism
Cerebral Cortex/microbiology
Cerebral Cortex/pathology*
Collagen Type IV/metabolism*
Disease Models, Animal
Immunohistochemistry
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9/metabolism*
Meningitis, Pneumococcal/metabolism
Meningitis, Pneumococcal/pathology
Meningitis, Pneumococcal/physiopathology*
Rats
Rats, Sprague-Dawley
Tissue Inhibitor of Metalloproteinase-1/metabolism*
Find related publications in this database (Keywords)
bacterial meningitis